154 related articles for article (PubMed ID: 9437200)
1. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.
Tilly-Kiesi M; Lichtenstein AH; Joven J; Vilella E; Cheung MC; Carrasco WV; Ordovas JM; Dolnikowski G; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3513-8. PubMed ID: 9437200
[TBL] [Abstract][Full Text] [Related]
2. Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).
Tilly-Kiesi M; Lichtenstein AH; Ordovas JM; Dolnikowski G; Malmström R; Taskinen MR; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):873-80. PubMed ID: 9157950
[TBL] [Abstract][Full Text] [Related]
3. ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.
Kido T; Kondo K; Kurata H; Fujiwara Y; Urata T; Itakura H; Yokoyama S
Lipids Health Dis; 2017 Nov; 16(1):225. PubMed ID: 29187200
[TBL] [Abstract][Full Text] [Related]
4. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations.
James RW; Pometta D
Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929
[TBL] [Abstract][Full Text] [Related]
5. HDL subparticles and coronary artery disease in NIDDM.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
[TBL] [Abstract][Full Text] [Related]
6. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.
Couillard C; Bergeron J; Després JP; Gagnon J; Rankinen T; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
Metabolism; 2003 Dec; 52(12):1530-6. PubMed ID: 14669150
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.
Kido T; Kurata H; Kondo K; Itakura H; Okazaki M; Urata T; Yokoyama S
Sci Rep; 2016 Aug; 6():31532. PubMed ID: 27526664
[TBL] [Abstract][Full Text] [Related]
10. Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0).
Tilly-Kiesi M; Lichtenstein AH; Rintarahko J; Taskinen MR
Atherosclerosis; 1998 Mar; 137(1):37-47. PubMed ID: 9568735
[TBL] [Abstract][Full Text] [Related]
11. Production rate determines plasma concentration of large high density lipoprotein in non-human primates.
Colvin P; Moriguchi E; Barrett H; Parks J; Rudel L
J Lipid Res; 1998 Oct; 39(10):2076-85. PubMed ID: 9788254
[TBL] [Abstract][Full Text] [Related]
12. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.
Vélez-Carrasco W; Lichtenstein AH; Welty FK; Li Z; Lamon-Fava S; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):918-24. PubMed ID: 10195918
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.
Velez-Carrasco W; Lichtenstein AH; Li Z; Dolnikowski GG; Lamon-Fava S; Welty FK; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):801-6. PubMed ID: 10712406
[TBL] [Abstract][Full Text] [Related]
14. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
15. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.
Gottrand F; Beghin L; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
Eur J Clin Invest; 1999 May; 29(5):387-94. PubMed ID: 10354195
[TBL] [Abstract][Full Text] [Related]
16. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
17. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
Brinton EA; Eisenberg S; Breslow JL
Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
[TBL] [Abstract][Full Text] [Related]
18. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P
Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468
[TBL] [Abstract][Full Text] [Related]
19. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
[TBL] [Abstract][Full Text] [Related]
20. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates.
Colvin PL; Moriguchi E; Barrett PH; Parks JS; Rudel LL
J Lipid Res; 1999 Oct; 40(10):1782-92. PubMed ID: 10508197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
